Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

What is the Immune System?01:38

What is the Immune System?

132.4K
Overview
132.4K
Lung Capacity01:47

Lung Capacity

56.4K
The air in the lungs is measured in volumes and capacities. Lung volume measures reflect the amount of air taken in, released, or left over after a lung function, like a single inhalation. Lung capacity measures are sums of two or more lung volume measures.
56.4K
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

84.2K
Overview
84.2K
Cells of the Adaptive Immune Response01:23

Cells of the Adaptive Immune Response

9.1K
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
9.1K
Humoral Immune Responses01:36

Humoral Immune Responses

84.1K
Overview
84.1K
Cells of the Innate Immune Response01:28

Cells of the Innate Immune Response

9.4K
The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
9.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Afatinib Overcomes Osimertinib Resistance via Egfr V804F Mutation in a Syngeneic Egfr-Mutant Lung Cancer Mouse Model.

Cancer science·2026
Same author

Pulmonary Infarction Secondary to Prostatitis-induced Venous Thromboembolism Mimicking Lobar Pneumonia in a Young Patient: A Diagnostic Pitfall.

Internal medicine (Tokyo, Japan)·2026
Same author

Mitochondrial Transfer-Driven Immune Evasion in the Tumor Microenvironment.

International immunology·2026
Same author

Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr-mutated lung cancer.

Molecular oncology·2026
Same author

Incidence of B cell malignancies in patients with lung cancer receiving PD-1 blockade therapy.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

Extracellular Vesicle from <i>Chlorella vulgaris</i> Alleviates Hepatic Fibrosis in a Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease Through Modulation of Inflammatory Signaling.

International journal of molecular sciences·2026

Related Experiment Video

Updated: Feb 12, 2026

Radiosensitivity of Cancer Stem Cells in Lung Cancer Cell Lines
09:45

Radiosensitivity of Cancer Stem Cells in Lung Cancer Cell Lines

Published on: August 21, 2019

7.5K

T-Cell Immunity and Lung Cancer.

Kotaro Yamada1, Yosuke Togashi1,2,3

  • 1Department of Respiratory Medicine, Okayama University Hospital, Okayama, Japan.

Respirology (Carlton, Vic.)
|February 11, 2026
PubMed
Summary
This summary is machine-generated.

T cells are crucial for lung cancer immunity and immunotherapy effectiveness. Understanding T-cell exhaustion, regulation, and the tumor microenvironment is key to improving treatments and patient outcomes.

Keywords:
T follicular helper cellsT‐cell exhaustionT‐lymphocytes cytotoxicT‐lymphocytes regulatoryimmune checkpoint inhibitorslung neoplasmstumour microenvironment

More Related Videos

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing
05:17

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing

Published on: October 10, 2025

428
Flow Cytometric Analysis for Identification of the Innate and Adaptive Immune Cells of Murine Lung
09:57

Flow Cytometric Analysis for Identification of the Innate and Adaptive Immune Cells of Murine Lung

Published on: November 16, 2021

8.0K

Related Experiment Videos

Last Updated: Feb 12, 2026

Radiosensitivity of Cancer Stem Cells in Lung Cancer Cell Lines
09:45

Radiosensitivity of Cancer Stem Cells in Lung Cancer Cell Lines

Published on: August 21, 2019

7.5K
Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing
05:17

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing

Published on: October 10, 2025

428
Flow Cytometric Analysis for Identification of the Innate and Adaptive Immune Cells of Murine Lung
09:57

Flow Cytometric Analysis for Identification of the Innate and Adaptive Immune Cells of Murine Lung

Published on: November 16, 2021

8.0K

Area of Science:

  • Immunology
  • Oncology
  • Cancer Research

Background:

  • Lung cancer is a major global health concern with limited therapeutic options.
  • Immune checkpoint inhibitors (ICIs) have advanced lung cancer treatment but have limitations.
  • T cells play a central role in antitumor immunity and response to ICIs.

Purpose of the Study:

  • To review the multifaceted roles of T cells in lung cancer.
  • To summarize recent advancements in understanding T-cell-mediated antitumor immunity.
  • To explore factors influencing T-cell function and therapeutic efficacy.

Main Methods:

  • Literature review of T-cell roles in lung cancer.
  • Analysis of T-cell subsets (CD8+, regulatory T cells) and their functions.
  • Examination of tertiary lymphoid structures (TLSs) and tumor microenvironment (TME) effects.

Main Results:

  • Tumor-specific CD8+ T cells are vital but can become exhausted.
  • Regulatory T cells suppress antitumor responses and affect outcomes.
  • TLSs can enhance local immunity, correlating with better prognosis and treatment response.
  • Tumor microenvironment metabolism impacts T-cell persistence and differentiation.

Conclusions:

  • Optimizing immunotherapy requires a deep understanding of T-cell functional states.
  • Targeting T-cell regulatory circuits can improve treatment efficacy.
  • Further research into T-cell biology in lung cancer is essential for durable clinical benefit.